Crossmark

Pediatric-Specific Drug Loss Issue in Japan: Comparison of Pediatric Development Status Between Japan and the United States

Published Online: 2024-10-23

Published Print: 2025-01

Authors

Osako, Ryohei

Matsumaru, Naoki

Tsukamoto, Katsura
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 16 April 2024

Accepted: 12 October 2024

First Online: 23 October 2024

Declarations

:

: Ryohei Osako is an employee of Novartis Pharma K.K., Tokyo, Japan. Naoki Matsumaru and Katsura Tsukamoto declare no competing interests.

Document is current